FDA Approved: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Pioglitazone hydrochloride and metformin hydrochloride (Aurobindo Pharma Limited), a generic combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone hydrochloride and metformin hydrochloride (Pioglitazone hydrochloride and metformin hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE)